KDSKF News and Press, Koninklijke DSM NV

2024-07-30 09:58:18 ET More on DSM-Firmenich AG Aristotle Capital - DSM-Firmenich AG: Current Valuation Doesn't Fully Appreciate The Firmenich Merger DSM-Firmenich AG (KDSKF) Q1 2024 Earnings Call Transcript Historical earnings data for DSM-Firmenich AG Finan...

2024-05-16 08:00:00 ET Summary DSM-Firmenich was added to the ADR portfolio after the merger of DSM and Firmenich. DSM-Firmenich is a Dutch-Swiss multinational corporation that produces flavors, fragrances, and active ingredients for various products. The company has undergone...

2024-05-15 10:20:00 ET Summary Aristotle Capital Management is an independent/employee-owned investment management organization that specializes in equity and fixed income portfolio management for institutional and advisory clients worldwide. Global equity markets continued to cli...

2024-05-04 15:20:06 ET DSM-Firmenich AG (KDSKF) Q1 2024 Earnings Conference Call May 2, 2024 03:00 ET Company Participants Dave Huizing - Head of Investor Relations Ralf Schmeitz - Chief Financial Officer Conference Call Participants Charles Eden - UBS ...

2024-04-25 12:05:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron International Growth Fund gained 1.35% during the first quarter of 2024, while i...

2024-03-22 04:03:34 ET Summary DSM-Firmenich reports underwhelming results in the challenging vitamin market and plans to separate Animal Nutrition & Health business in 2025. The company continues to invest heavily in R&D, with recent breakthroughs including the creation o...

2024-03-15 10:05:53 ET Summary Givaudan continues to deliver solid results. FY2023 sales up 4.1% on an LFL basis and gross margins improve. Positive medium-term growth outlook as Givaudan's innovation efforts could help the company outpace overall industry growth. Productivity...

2023-08-09 11:30:00 ET Summary VGI Partners Global Investments Limited is an Australia-based investment company. The Company’s Investment Strategy is to create a concentrated Portfolio, predominantly comprised of Long and Short Positions in global listed securities, actively ma...

2023-08-04 01:43:07 ET DSM-Firmenich AG (KDSKF) Q2 2023 Earnings Conference Call August 02, 2023 08:00 AM ET Company Participants Dave Huizing - Head-Investor Relations Geraldine Matchett - Co-Chief Executive Officer Dimitri de Vreeze - Co-Chief Executive Officer...

2023-08-02 09:53:04 ET DSM-Firmenich AG press release ( OTCPK:KDSKF ): 1H Revenue of €6.15B (-5.2% Y/Y). Net profit of €236M For further details see: DSM-Firmenich AG reports 1H results